0001562180-19-002196.txt : 20190403 0001562180-19-002196.hdr.sgml : 20190403 20190403174403 ACCESSION NUMBER: 0001562180-19-002196 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190401 FILED AS OF DATE: 20190403 DATE AS OF CHANGE: 20190403 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Azoy Alexander CENTRAL INDEX KEY: 0001771961 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38155 FILM NUMBER: 19730333 MAIL ADDRESS: STREET 1: 30699 RUSSELL RANCH ROAD, SUITE 140 CITY: WESTLAKE VILLAGE STATE: CA ZIP: 91362 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sienna Biopharmaceuticals, Inc. CENTRAL INDEX KEY: 0001656328 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 273364627 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 30699 RUSSELL RANCH ROAD, SUITE 140 CITY: WESTLAKE VILLAGE STATE: CA ZIP: 91362 BUSINESS PHONE: (818) 629-2256 MAIL ADDRESS: STREET 1: 30699 RUSSELL RANCH ROAD, SUITE 140 CITY: WESTLAKE VILLAGE STATE: CA ZIP: 91362 FORMER COMPANY: FORMER CONFORMED NAME: Sienna Labs, Inc. DATE OF NAME CHANGE: 20151020 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2019-04-01 false 0001656328 Sienna Biopharmaceuticals, Inc. SNNA 0001771961 Azoy Alexander 30699 RUSSELL RANCH ROAD SUITE 140 WESTLAKE VILLAGE CA 91362 false true false false Chief Financial Officer Common Stock 2019-04-01 4 A false 20000.00 A 37500.00 D Stock Options (Right to buy) 2.37 2019-04-01 4 A false 20000.00 0.00 A 2029-04-01 Common Stock 20000.00 20000.00 D Award of restricted stock units ("RSUs") granted under the Issuer's 2017 Incentive Award Plan. Each RSU entitles the Reporting Person to receive one share of Issuer's common stock upon vesting. The award vests as to twenty-five percent (25%) of the total number of RSUs on October 1, 2019, twenty-five percent (25%) of the total number of RSUs on April 1, 2020, and the remaining fifty percent (50%) of the total number of RSUs on the second anniversary, in each case, subject to the Reporting Person's continued employment or service relationship with the Issuer through the applicable vesting date. Includes 17,500 shares of the Issuer's common stock underlying the RSUs awarded. Twenty-five percent (25%) of the shares subject to the option vest and become exercisable on October 1, 2019, twenty-five percent (25%) of the shares vest and become exercisable on April 1, 2020, and the remaining shares vest and become exercisable in 12 successive, equal monthly installments thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. /s/Timothy K. Andrews, attorney-in-fact for Alexander Azoy 2019-04-03